PanGen Biotech Inc. (KOSDAQ:222110)

PanGen Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	81,910	73,520	73,462	69,405	99,783	97,864
Market Cap Growth	-10.66%	0.08%	5.85%	-30.44%	1.96%	30.63%
Enterprise Value	65,749	69,814	74,767	67,446	92,638	96,121
Last Close Price	6070.00	5700.00	6880.00	6500.00	9350.00	10150.00
PE Ratio	32.78	77.91	-	-	-	-
Forward PE	-	91.30	91.30	91.30	91.30	91.30
PS Ratio	5.17	5.01	10.04	10.68	12.57	15.81
PB Ratio	2.78	2.95	5.85	4.03	4.73	6.89
P/TBV Ratio	2.85	3.05	6.29	4.10	4.80	7.02
P/FCF Ratio	19.55	27.99	-	-	-	-
P/OCF Ratio	17.25	24.61	-	-	-	-
EV/Sales Ratio	4.15	4.76	10.22	10.38	11.67	15.53
EV/EBITDA Ratio	16.24	28.06	-	-	-	-
EV/EBIT Ratio	25.39	68.43	-	-	-	-
EV/FCF Ratio	15.69	26.58	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.16	0	0.89	1.30
Debt / EBITDA Ratio	0.28	0.33	-	-	-	-
Debt / FCF Ratio	0.41	0.31	-	-	-	-
Asset Turnover	0.53	0.57	0.35	0.20	0.20	0.16
Inventory Turnover	1.33	1.48	0.94	1.07	1.82	2.12
Quick Ratio	5.86	4.98	0.42	1.55	1.28	0.97
Current Ratio	8.79	7.16	1.72	7.59	1.57	1.20
Return on Equity (ROE)	7.63%	5.04%	-30.14%	-23.46%	-18.75%	-26.69%
Return on Assets (ROA)	3.71%	2.49%	-12.75%	-8.97%	-5.17%	-6.13%
Return on Capital (ROIC)	4.53%	3.16%	-16.61%	-10.06%	-5.68%	-6.76%
Return on Capital Employed (ROCE)	5.80%	3.70%	-	-	-	-
Earnings Yield	2.80%	1.28%	-6.11%	-6.48%	-3.32%	-4.45%
FCF Yield	5.12%	3.57%	-5.27%	-6.10%	-4.76%	-5.56%
Buyback Yield / Dilution	-10.07%	-7.03%	-0.13%	-4.47%	-6.02%	0.04%

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.